BioSmart Research, with a valuation cap of $20 million, is raising funds on Wefunder. The company is making over-the-counter CBD nutraceuticals for pain management, anxiety, skincare, and neurological disorders. BioSmart Research uses chromatography technologies to produce specific cannabinoid formulas to treat specific conditions. B Renee Searle founded BioSmart Research in March 2019. The current crowdfunding round has a minimum target of $50,000 and a maximum target of $1,070,000, and the funds will be used for marketing expenses, paying off an existing equipment note, opening a retail dispensary, and inventories. BioSmart Research sells through its own dispensaries, healthcare providers, pharmacies, and affiliates and has generated $1.7 million in lifetime sales.